Скачать или смотреть Novartis and Glaxo Deal Reshapes Pharma Industry

Novartis completed about $25 billion of transactions in its product portfolios, including the sale of two units to British-based GlaxoSmithKline. Hester Plumridge explains why the Swiss company is doing these deals now and what this means for the pharmaceutical industry.

Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy

Visit the WSJ channel for more video:
   / wsjdigitalnetwork  
More from the Wall Street Journal:
Visit WSJ.com: http://online.wsj.com/home-page

Follow WSJ on Facebook:
  / wsjlive  
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter:   / wsjlive  
Follow WSJ on Instagram:   / wsj  
Follow WSJ on Pinterest:   / wsj  
Follow WSJ on Tumblr: http://www.tumblr.com/tagged/wall-str...
Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy

More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video

On Facebook:   / videos  
On Twitter:   / wsj  
On Snapchat: https://on.wsj.com/2ratjSM